Medicus Pharma Correlations

MDCX Stock  USD 2.75  0.05  1.79%   
The current 90-days correlation between Medicus Pharma and Dogwood Therapeutics, is 0.04 (i.e., Significant diversification). The correlation of Medicus Pharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Medicus Pharma Correlation With Market

Significant diversification

The correlation between Medicus Pharma Ltd and DJI is 0.01 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Medicus Pharma Ltd and DJI in the same portfolio, assuming nothing else is changed.
  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Medicus Pharma Ltd. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

Moving against Medicus OTC BB Equity

  0.32CYCCP Cyclacel PharmaceuticalsPairCorr
  0.39XOMAP XOMA CorpPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
IRDDWTX
CEROWEPRX
TLXIRD
TLXDWTX
  
High negative correlations   
IRDEPRX
EPRXDWTX
IRDCEROW
CEROWDWTX
TLXCEROW
TLXEPRX

Risk-Adjusted Indicators

There is a big difference between Medicus OTC BB Equity performing well and Medicus Pharma Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Medicus Pharma's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.